Abstract
Background: Poor pharmacokinetic profile, bioavailability, solubility and toxicity to healthy tissues hamper clinical application. Encapsulation of gedunin from the neem plant possessing anticancer potential, in chitosan nanoparticles, may overcome these issues and increase antiproliferative property.
Methods: Chitosan nanoparticles were prepared by an ionic gelation method. Cells were exposed to gedunin (1.5625 - 50 µg/mL) and the nanoformulation (0.469 - 15 µg/mL) for 24, 48 and 72 h, with paclitaxel as the positive control. Their inhibitory activities were investigated by Sulphorhodamine B assay, coupled with microscopic visualization through a phase-contrast microscope.
Results: Encapsulation efficiency of gedunin in chitosan was 98 %, with average particle size of 163.2 ± 24.28, and a zeta potential of +24.2 ± 3.75. Dose- and time-dependent cytomorphological changes resulting in cell death were observed. Nano-gedunin demonstrated much higher antiproliferative activities against NCI-H292 cells at significant levels (p < 0.05). The mean IC50 values for gedunin were approximately 26, 23, and 20 µg/mL at 24, 48, and 72 h, respectively. In contrast, chitosan- encapsulated gedunin recorded a 3 to 8-fold decrease (7.5, 5, and 2 µg/mL).
Conclusion: The chitosan nano-delivery system enhanced the cytotoxic activity of gedunin in vitro against NCI-H292 cells and reduced cytotoxicity towards normal lung fibroblast cells (MRC-5).
Keywords: Apoptosis, lung cancer, chitosan, nanoencapsulation, gedunin, cytotoxicity., Apoptosis, lung cancer, chitosan, nanoencapsulation, gedunin, cytotoxicity.
Drug Delivery Letters
Title:Chitosan Nano-encapsulation Enhances Gedunin Cytotoxicity A gainst Human Non-small-cell Lung Cancer (NCI-H292) Cell Line
Volume: 7 Issue: 3
Author(s): Chukwumaobim D.U. Nwokwu, Chukwumaobim D.U. Nwokwu, Sameera R. Samarakoon, Sameera R. Samarakoon, Desiree N. Karunaratne*, Desiree N. Karunaratne*, Nuwanthi P. Katuvawila, Nuwanthi P. Katuvawila, Meran K. Ediriweera, Meran K. Ediriweera, Kamani H. Tennekoon and Kamani H. Tennekoon
Affiliation:
- Department of Chemistry, University of Peradeniya,Sri Lanka
- Department of Chemistry, University of Peradeniya,Sri Lanka
Keywords: Apoptosis, lung cancer, chitosan, nanoencapsulation, gedunin, cytotoxicity., Apoptosis, lung cancer, chitosan, nanoencapsulation, gedunin, cytotoxicity.
Abstract: Background: Poor pharmacokinetic profile, bioavailability, solubility and toxicity to healthy tissues hamper clinical application. Encapsulation of gedunin from the neem plant possessing anticancer potential, in chitosan nanoparticles, may overcome these issues and increase antiproliferative property.
Methods: Chitosan nanoparticles were prepared by an ionic gelation method. Cells were exposed to gedunin (1.5625 - 50 µg/mL) and the nanoformulation (0.469 - 15 µg/mL) for 24, 48 and 72 h, with paclitaxel as the positive control. Their inhibitory activities were investigated by Sulphorhodamine B assay, coupled with microscopic visualization through a phase-contrast microscope.
Results: Encapsulation efficiency of gedunin in chitosan was 98 %, with average particle size of 163.2 ± 24.28, and a zeta potential of +24.2 ± 3.75. Dose- and time-dependent cytomorphological changes resulting in cell death were observed. Nano-gedunin demonstrated much higher antiproliferative activities against NCI-H292 cells at significant levels (p < 0.05). The mean IC50 values for gedunin were approximately 26, 23, and 20 µg/mL at 24, 48, and 72 h, respectively. In contrast, chitosan- encapsulated gedunin recorded a 3 to 8-fold decrease (7.5, 5, and 2 µg/mL).
Conclusion: The chitosan nano-delivery system enhanced the cytotoxic activity of gedunin in vitro against NCI-H292 cells and reduced cytotoxicity towards normal lung fibroblast cells (MRC-5).
Export Options
About this article
Cite this article as:
Nwokwu D.U. Chukwumaobim , Nwokwu D.U. Chukwumaobim , Samarakoon R. Sameera, Samarakoon R. Sameera, Karunaratne N. Desiree *, Karunaratne N. Desiree *, Katuvawila P. Nuwanthi , Katuvawila P. Nuwanthi , Ediriweera K. Meran , Ediriweera K. Meran , Tennekoon H. Kamani and Tennekoon H. Kamani , Chitosan Nano-encapsulation Enhances Gedunin Cytotoxicity A gainst Human Non-small-cell Lung Cancer (NCI-H292) Cell Line, Drug Delivery Letters 2017; 7 (3) . https://dx.doi.org/10.2174/2210303107666170808110740
DOI https://dx.doi.org/10.2174/2210303107666170808110740 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Current Cancer Drug Targets Developments of Anticoagulants and New Agents with Anti-Coagulant Effects in Deep Vein Thrombosis
Mini-Reviews in Medicinal Chemistry Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management
Current Vascular Pharmacology Novel Synthetic Lethality Approaches for Drug Combinations and Early Drug Development
Current Cancer Drug Targets The Role of Coagulation and Fibrinolysis in the Pathogenesis of Acute Lung Injury
Current Respiratory Medicine Reviews The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Editorial (Thematic Issue: Endocrine Related Cancer: From Stem Cells to New Drug Targets)
Current Medicinal Chemistry Harnessing the Power of Cerenkov Luminescence Imaging for Gastroenterology: Cerenkov Luminescence Endoscopy
Current Medical Imaging Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Recent Patents on Anti-Cancer Drug Discovery Transporter-Based Delivery of Anticancer Drugs to the Brain: Improving Brain Penetration by Minimizing Drug Efflux at the Blood-Brain Barrier
Current Pharmaceutical Design Hybridized Quinoline Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and Molecular Docking
Anti-Cancer Agents in Medicinal Chemistry Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis
Medicinal Chemistry A Sensitive Determination of Ammonia and Nitrite in Exhaled Breath Condensate of Healthy Humans by Using Berthelot Reaction
Current Pharmaceutical Analysis DNA Vaccines to Improve Immunogenicity and Effectiveness in Cancer Vaccinations: Advancement and Developments
Current Gene Therapy Alzheimer’s Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy
Current Pharmaceutical Design Biological Carrier Molecules of Radiopharmaceuticals for Molecular Cancer Imaging and Targeted Cancer Therapy
Current Pharmaceutical Design Peroxisome Proliferator-activated Receptor-γ As A Novel and Promising Target For Treating Cancer <i>Via</i> Regulation of Inflammation: A Brief Review
Mini-Reviews in Medicinal Chemistry Targeting Cancer Using Fragment Based Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Electrocatalytic Determination of 6-Mercaptopurine Using Multiwall Carbon Nanotubes Paste Electrode in the Presence of Methyldopa
Current Nanoscience Wealth of Opportunity - The C1 Domain as a Target for Drug Development
Current Drug Targets